These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31243595)

  • 1. Clinical characteristics and treatment outcomes of Enterococcus durans bacteremia: a 20-year experience in a tertiary care hospital.
    Ryu BH; Hong J; Jung J; Kim MJ; Sung H; Kim MN; Chong YP; Kim SH; Lee SO; Kim YS; Woo JH; Choi SH
    Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1743-1751. PubMed ID: 31243595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 10-year profile of enterococcal bloodstream infections at a tertiary-care hospital in Japan.
    Suzuki H; Hase R; Otsuka Y; Hosokawa N
    J Infect Chemother; 2017 Jun; 23(6):390-393. PubMed ID: 28385565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients.
    Ghanem G; Hachem R; Jiang Y; Chemaly RF; Raad I
    Infect Control Hosp Epidemiol; 2007 Sep; 28(9):1054-9. PubMed ID: 17932826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections.
    Kramer TS; Remschmidt C; Werner S; Behnke M; Schwab F; Werner G; Gastmeier P; Leistner R
    Antimicrob Resist Infect Control; 2018; 7():133. PubMed ID: 30459945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of 117 episodes of enterococcal bacteremia: Study of epidemiology, microbiology and antimicrobial susceptibility].
    Manassero NC; Navarro M; Rocchi M; di Bella H; Gasparotto AM; Ocaña Carrizo AV; Novillo F; Furiasse D; Monterisi A
    Rev Argent Microbiol; 2016; 48(4):298-302. PubMed ID: 27567523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
    Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
    J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the clinical characteristics and outcomes associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant E. faecium bacteremia.
    Hayakawa K; Marchaim D; Martin ET; Tiwari N; Yousuf A; Sunkara B; Pulluru H; Kotra H; Hasan A; Bheemreddy S; Sheth P; Lee DW; Kamatam S; Bathina P; Nanjireddy P; Chalana IK; Patel S; Kumar S; Vahia A; Ku K; Yee V; Swan J; Pogue JM; Lephart PR; Rybak MJ; Kaye KS
    Antimicrob Agents Chemother; 2012 May; 56(5):2452-8. PubMed ID: 22354290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic relatedness and risk factor analysis of ampicillin-resistant and high-level gentamicin-resistant enterococci causing bloodstream infections in Tanzanian children.
    Aamodt H; Mohn SC; Maselle S; Manji KP; Willems R; Jureen R; Langeland N; Blomberg B
    BMC Infect Dis; 2015 Feb; 15():107. PubMed ID: 25884316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enterococcal Bacteremia in Children With Malignancies and Following Hematopoietic Stem Cell Transplantation: A 15-Year Single-Center Experience.
    Friedman G; Stepensky P; Abu Ahmad W; Masarwa R; Temper V; Oster Y; Amit S; Averbuch D
    Pediatr Infect Dis J; 2020 Apr; 39(4):318-324. PubMed ID: 31990889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors and outcomes associated with non-Enterococcus faecalis, non-Enterococcus faecium enterococcal bacteremia.
    de Perio MA; Yarnold PR; Warren J; Noskin GA
    Infect Control Hosp Epidemiol; 2006 Jan; 27(1):28-33. PubMed ID: 16418983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia.
    Bhavnani SM; Drake JA; Forrest A; Deinhart JA; Jones RN; Biedenbach DJ; Ballow CH
    Diagn Microbiol Infect Dis; 2000 Mar; 36(3):145-58. PubMed ID: 10729656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Australian Enterococcal Sepsis Outcome Programme annual report, 2013.
    Coombs GW; Pearson JC; Daly DA; Le TT; Robinson JO; Gottlieb T; Howden BP; Johnson PD; Bennett CM; Stinear TP; Turnidge JD;
    Commun Dis Intell Q Rep; 2014 Dec; 38(4):E320-6. PubMed ID: 25631594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes.
    Lucas GM; Lechtzin N; Puryear DW; Yau LL; Flexner CW; Moore RD
    Clin Infect Dis; 1998 May; 26(5):1127-33. PubMed ID: 9597241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enterococcus raffinosus bacteremia: clinical experience with 49 adult patients.
    Lee YW; Lim SY; Jung J; Kim MJ; Chong YP; Kim SH; Lee SO; Kim YS; Choi SH
    Eur J Clin Microbiol Infect Dis; 2022 Mar; 41(3):415-420. PubMed ID: 34977997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single center experience of a vancomycin resistant enterococcal endocarditis cohort.
    Forrest GN; Arnold RS; Gammie JS; Gilliam BL
    J Infect; 2011 Dec; 63(6):420-8. PubMed ID: 21920382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium.
    Linden PK; Pasculle AW; Manez R; Kramer DJ; Fung JJ; Pinna AD; Kusne S
    Clin Infect Dis; 1996 Apr; 22(4):663-70. PubMed ID: 8729206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nosocomial bacteremia due to Enterococcus faecalis without endocarditis.
    Graninger W; Ragette R
    Clin Infect Dis; 1992 Jul; 15(1):49-57. PubMed ID: 1617073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enterococcal bacteremia in the surgical intensive care unit. Does vancomycin resistance affect mortality? The Johns Hopkins SICU Study Group.
    Mainous MR; Lipsett PA; O'Brien M
    Arch Surg; 1997 Jan; 132(1):76-81. PubMed ID: 9006556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bloodstream infections caused by Enterococcus spp: A 10-year retrospective analysis at a tertiary hospital in China.
    Zheng JX; Li H; Pu ZY; Wang HY; Deng XB; Liu XJ; Deng QW; Yu ZJ
    J Huazhong Univ Sci Technolog Med Sci; 2017 Apr; 37(2):257-263. PubMed ID: 28397040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infectious Diseases Consultation Improves Treatment and Decreases Mortality by Enterococcal Bacteremia in Children.
    Furuichi M; Furuichi M; Horikoshi Y; Miyairi I
    Pediatr Infect Dis J; 2018 Sep; 37(9):856-860. PubMed ID: 29384980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.